Invivac Injektionsvätska, suspension

Ülke: İsveç

Dil: İsveççe

Kaynak: Läkemedelsverket (Medical Products Agency)

Aktif bileşen:

influensavirus A/California/7/2004 (H3N2)-liknande stam (A/New York/55/2004 (NYMC X-157)), ytantigen, inaktiverat; influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat; influensavirus B/Shanghai/361/2002 - liknande stam (B/Jiangsu/10/2003), ytantigen, inaktiverat

Mevcut itibaren:

Abbott Biologicals B.V.

ATC kodu:

J07BB02

INN (International Adı):

the influenza virus A/California/7/2004 (H3N2)-like strain (A/New York/55/2004 (NYMC X-157)), surface antigen, inactivated; influenza virus (A/New Caledonia/20/99 (H1N1)-like strain (A/New Caledonia/20/99 (IVR-116)), surface antigen, inactivated; influenza virus B/Shanghai/361/2002 - like strain (B/Jiangsu/10/2003), a surface antigen, inactivated

Farmasötik formu:

Injektionsvätska, suspension

Kompozisyon:

influensavirus A/California/7/2004 (H3N2)-liknande stam (A/New York/55/2004 (NYMC X-157)), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus B/Shanghai/361/2002 - liknande stam (B/Jiangsu/10/2003), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat 15 mikrog Aktiv substans

Reçete türü:

Receptbelagt

Terapötik alanı:

spjälkat virus eller ytantigen

Yetkilendirme durumu:

Avregistrerad

Yetkilendirme tarihi:

2004-10-08